A Meeting of the Board of Directors will be held on Thursday, 12th November, 2026.
The primary agenda is to consider and approve the Unaudited Financial Results of the Company for the second quarter ended 30th September, 2026.
Additional Information
The financial results information will be hosted on the Company's website at www.ennaturebiopharma.com.
Pursuant to the Company's Code of Conduct and as previously intimated on 4th November 2026, the Trading Window for dealing in the securities of the Company remains closed.
The Trading Window closure period is from Wednesday, 4th November, 2026 to Saturday, 14th November, 2026 (both days inclusive).
Document & Company Information
Registered Offices & Locations
Registered Office & Head Office: P.No.4, Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India
Works: Plot No. 2,3,4 & 5 Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India
2B, Sector-126, Noida, Gautam Budh Nagar-201304, Uttar Pradesh, India
A-1, Industrial Area Bazpur Road, Kashipur, Udham Singh Nagar- 244713, Uttarakhand, India
